(Q37367174)

20 August 2017

1 reference

title

Anticoagulation in patients with heart failure and normal sinus rhythm (English)

1 reference

20 August 2017

0 references

1 reference

Toni L Ripley

1

1 reference

20 August 2017

Edith Nutescu

series ordinal

2

1 reference

20 August 2017

publication date

1 January 2009

1 reference

American Journal of Health-System Pharmacy

20 August 2017

published in

1 reference

20 August 2017

volume

66

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

134-141

1 reference

The polymorphonuclear leukocyte and the abdominal aortic aneurysm: a neglected cell type and a neglected disease

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Does heart failure confer a hypercoagulable state? Virchow's triad revisited

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Platelet function, thrombin and fibrinolytic activity in patients with heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Effects of warfarin on markers of hypercoagulability in patients with heart failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

The natural history of idiopathic dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Systemic thromboembolism in chronic heart failure. A prospective study in 406 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Low incidence of stroke in ambulatory patients with heart failure: A prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Fat-suppressed breath-hold magnetic resonance coronary angiography

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Ventricular dysfunction and the risk of stroke after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Silent strokes in patients with heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

The effect of dicumarol upon the mortality and incidence of thromboembolic complications in congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

A study of the beneficial effects of anticoagulant therapy in congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Dicumarol prophylaxis of thromboembolic disease in congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study)

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Both antiplatelet and anticoagulant therapy may favorably affect outcome in patients with advanced heart failure. A retrospective analysis of the PRIME-II trial

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

The effect of liver dysfunction on the response to dicumarol

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

The increased hypoprothrombinemic effect of a small dose of dicumarol in congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

The effect of digoxin on mortality and morbidity in patients with heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080047

31 March 2020

Identifiers

DOI

10.2146/AJHP080047

1 reference

20 August 2017

1 reference